학술논문
PND8 - PEGINTERFERON BETA-1A IS ASSOCIATED WITH REDUCED RELAPSE RATES AND HOSPITALISATIONS DUE TO RELAPSE COMPARED WITH OTHER FIRST-LINE INJECTABLE THERAPIES FOR MULTIPLE SCLEROSIS: FINDINGS FROM A REAL-WORLD CROSS-SECTIONAL STUDY
Document Type
Abstract
Author
Source
In Value in Health October 2018 21 Supplement 3:S330-S330
Subject
Language
ISSN
1098-3015